Annual Revenue
$202.00 K
+$61.00 K+43.26%
31 December 2023
Summary:
AIM ImmunoTech annual revenue is currently $202.00 thousand, with the most recent change of +$61.00 thousand (+43.26%) on 31 December 2023. During the last 3 years, it has risen by +$39.00 thousand (+23.93%). AIM annual revenue is now -93.27% below its all-time high of $3.00 million, reached on 31 December 1995.AIM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$35.00 K
-$15.00 K-30.00%
30 September 2024
Summary:
AIM ImmunoTech quarterly revenue is currently $35.00 thousand, with the most recent change of -$15.00 thousand (-30.00%) on 30 September 2024. Over the past year, it has dropped by -$11.00 thousand (-23.91%). AIM quarterly revenue is now -96.11% below its all-time high of $900.00 thousand, reached on 31 December 1995.AIM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$190.00 K
-$11.00 K-5.47%
30 September 2024
Summary:
AIM ImmunoTech TTM revenue is currently $190.00 thousand, with the most recent change of -$11.00 thousand (-5.47%) on 30 September 2024. Over the past year, it has dropped by -$3000.00 (-1.55%). AIM TTM revenue is now -93.67% below its all-time high of $3.00 million, reached on 31 December 1995.AIM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.3% | -23.9% | -1.6% |
| 3 y3 years | +23.9% | +6.1% | +50.8% |
| 5 y5 years | -45.0% | -42.6% | -42.4% |
AIM Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +49.6% | -46.1% | +66.7% | -5.9% | +50.8% |
| 5 y | 5 years | -45.0% | +49.6% | -46.1% | +66.7% | -42.4% | +50.8% |
| alltime | all time | -93.3% | +119.6% | -96.1% | +107.2% | -93.7% | +177.2% |
AIM ImmunoTech Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $35.00 K(-30.0%) | $190.00 K(-5.5%) |
| June 2024 | - | $50.00 K(+25.0%) | $201.00 K(+4.1%) |
| Mar 2024 | - | $40.00 K(-38.5%) | $193.00 K(-4.5%) |
| Dec 2023 | $202.00 K(+43.3%) | $65.00 K(+41.3%) | $202.00 K(+4.7%) |
| Sept 2023 | - | $46.00 K(+9.5%) | $193.00 K(+14.9%) |
| June 2023 | - | $42.00 K(-14.3%) | $168.00 K(+7.7%) |
| Mar 2023 | - | $49.00 K(-12.5%) | $156.00 K(+11.4%) |
| Dec 2022 | $141.00 K(+4.4%) | $56.00 K(+166.7%) | $140.00 K(+4.5%) |
| Sept 2022 | - | $21.00 K(-30.0%) | $134.00 K(-8.2%) |
| June 2022 | - | $30.00 K(-9.1%) | $146.00 K(+5.0%) |
| Mar 2022 | - | $33.00 K(-34.0%) | $139.00 K(+3.7%) |
| Dec 2021 | $135.00 K(-17.2%) | $50.00 K(+51.5%) | $134.00 K(+6.3%) |
| Sept 2021 | - | $33.00 K(+43.5%) | $126.00 K(-2.3%) |
| June 2021 | - | $23.00 K(-17.9%) | $129.00 K(-11.6%) |
| Mar 2021 | - | $28.00 K(-33.3%) | $146.00 K(-10.4%) |
| Dec 2020 | $163.00 K(+16.4%) | $42.00 K(+16.7%) | $163.00 K(-4.7%) |
| Sept 2020 | - | $36.00 K(-10.0%) | $171.00 K(-12.8%) |
| June 2020 | - | $40.00 K(-11.1%) | $196.00 K(+5.9%) |
| Mar 2020 | - | $45.00 K(-10.0%) | $185.00 K(+32.1%) |
| Dec 2019 | $140.00 K(-61.9%) | $50.00 K(-18.0%) | $140.00 K(-57.6%) |
| Sept 2019 | - | $61.00 K(+110.3%) | $330.00 K(+7.5%) |
| June 2019 | - | $29.00 K(-87.9%) | $307.00 K(-16.3%) |
| Dec 2018 | $367.00 K(-16.0%) | $240.00 K(+531.6%) | $367.00 K(+107.3%) |
| Sept 2018 | - | $38.00 K(+15.2%) | $177.00 K(-22.7%) |
| June 2018 | - | $33.00 K(-41.1%) | $229.00 K(-44.0%) |
| Mar 2018 | - | $56.00 K(+12.0%) | $409.00 K(-6.4%) |
| Dec 2017 | $437.00 K(+375.0%) | $50.00 K(-44.4%) | $437.00 K(+8.4%) |
| Sept 2017 | - | $90.00 K(-57.7%) | $403.00 K(+20.3%) |
| June 2017 | - | $213.00 K(+153.6%) | $335.00 K(+144.5%) |
| Mar 2017 | - | $84.00 K(+425.0%) | $137.00 K(+48.9%) |
| Dec 2016 | $92.00 K(-30.8%) | $16.00 K(-27.3%) | $92.00 K(-10.7%) |
| Sept 2016 | - | $22.00 K(+46.7%) | $103.00 K(-1.0%) |
| June 2016 | - | $15.00 K(-61.5%) | $104.00 K(-23.5%) |
| Mar 2016 | - | $39.00 K(+44.4%) | $136.00 K(+2.3%) |
| Dec 2015 | $133.00 K(-32.5%) | $27.00 K(+17.4%) | $133.00 K(-8.9%) |
| Sept 2015 | - | $23.00 K(-51.1%) | $146.00 K(-13.1%) |
| June 2015 | - | $47.00 K(+30.6%) | $168.00 K(+7.0%) |
| Mar 2015 | - | $36.00 K(-10.0%) | $157.00 K(-20.3%) |
| Dec 2014 | $197.00 K(+31.3%) | $40.00 K(-11.1%) | $197.00 K(+2.1%) |
| Sept 2014 | - | $45.00 K(+25.0%) | $193.00 K(+4.9%) |
| June 2014 | - | $36.00 K(-52.6%) | $184.00 K(0.0%) |
| Mar 2014 | - | $76.00 K(+111.1%) | $184.00 K(+22.7%) |
| Dec 2013 | $150.00 K(-29.6%) | $36.00 K(0.0%) | $150.00 K(-10.2%) |
| Sept 2013 | - | $36.00 K(0.0%) | $167.00 K(-1.8%) |
| June 2013 | - | $36.00 K(-14.3%) | $170.00 K(-7.1%) |
| Mar 2013 | - | $42.00 K(-20.8%) | $183.00 K(-14.1%) |
| Dec 2012 | $213.00 K(+32.3%) | $53.00 K(+35.9%) | $213.00 K(+7.6%) |
| Sept 2012 | - | $39.00 K(-20.4%) | $198.00 K(-2.9%) |
| June 2012 | - | $49.00 K(-31.9%) | $204.00 K(+6.8%) |
| Mar 2012 | - | $72.00 K(+89.5%) | $191.00 K(+18.6%) |
| Dec 2011 | $161.00 K(+19.3%) | $38.00 K(-15.6%) | $161.00 K(+7.3%) |
| Sept 2011 | - | $45.00 K(+25.0%) | $150.00 K(+7.1%) |
| June 2011 | - | $36.00 K(-14.3%) | $140.00 K(-3.4%) |
| Mar 2011 | - | $42.00 K(+55.6%) | $145.00 K(+7.4%) |
| Dec 2010 | $135.00 K(+21.6%) | $27.00 K(-22.9%) | $135.00 K(-8.8%) |
| Sept 2010 | - | $35.00 K(-14.6%) | $148.00 K(+7.2%) |
| June 2010 | - | $41.00 K(+28.1%) | $138.00 K(+21.1%) |
| Mar 2010 | - | $32.00 K(-20.0%) | $114.00 K(+2.7%) |
| Dec 2009 | $111.00 K | $40.00 K(+60.0%) | $111.00 K(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $25.00 K(+47.1%) | $96.00 K(+9.1%) |
| June 2009 | - | $17.00 K(-41.4%) | $88.00 K(+2.3%) |
| Mar 2009 | - | $29.00 K(+16.0%) | $86.00 K(-67.5%) |
| Dec 2008 | $265.00 K(-75.0%) | $25.00 K(+47.1%) | $265.00 K(-49.5%) |
| Sept 2008 | - | $17.00 K(+13.3%) | $525.00 K(-33.8%) |
| June 2008 | - | $15.00 K(-92.8%) | $793.00 K(-21.6%) |
| Mar 2008 | - | $208.00 K(-27.0%) | $1.01 M(-4.4%) |
| Dec 2007 | $1.06 M(+13.5%) | $285.00 K(0.0%) | $1.06 M(+6.8%) |
| Sept 2007 | - | $285.00 K(+21.8%) | $992.00 K(+5.6%) |
| June 2007 | - | $234.00 K(-8.2%) | $939.00 K(-1.4%) |
| Mar 2007 | - | $255.00 K(+17.0%) | $952.00 K(+2.0%) |
| Dec 2006 | $933.00 K(-13.9%) | $218.00 K(-6.0%) | $933.00 K(-3.7%) |
| Sept 2006 | - | $232.00 K(-6.1%) | $969.00 K(-3.9%) |
| June 2006 | - | $247.00 K(+4.7%) | $1.01 M(-5.0%) |
| Mar 2006 | - | $236.00 K(-7.1%) | $1.06 M(-2.0%) |
| Dec 2005 | $1.08 M(-11.9%) | $254.00 K(-6.3%) | $1.08 M(-5.9%) |
| Sept 2005 | - | $271.00 K(-9.7%) | $1.15 M(+1.1%) |
| June 2005 | - | $300.00 K(+16.3%) | $1.14 M(-2.7%) |
| Mar 2005 | - | $258.00 K(-19.9%) | $1.17 M(-4.1%) |
| Dec 2004 | $1.23 M(+87.1%) | $322.00 K(+24.8%) | $1.22 M(+1.6%) |
| Sept 2004 | - | $258.00 K(-22.1%) | $1.20 M(+5.6%) |
| June 2004 | - | $331.00 K(+7.5%) | $1.14 M(+26.4%) |
| Mar 2004 | - | $308.00 K(+1.7%) | $899.00 K(+36.8%) |
| Dec 2003 | $657.00 K(+92.7%) | $303.00 K(+56.2%) | $657.00 K(-601.5%) |
| Sept 2003 | - | $194.00 K(+106.4%) | -$131.00 K(-46.7%) |
| June 2003 | - | $94.00 K(+42.4%) | -$246.00 K(+19.4%) |
| Mar 2003 | - | $66.00 K(-113.6%) | -$206.00 K(-160.4%) |
| Dec 2002 | $341.00 K(-12.6%) | -$485.00 K(-713.9%) | $341.00 K(-62.6%) |
| Sept 2002 | - | $79.00 K(-41.0%) | $912.00 K(+0.3%) |
| June 2002 | - | $134.00 K(-78.1%) | $909.00 K(+3.8%) |
| Mar 2002 | - | $613.00 K(+612.8%) | $876.00 K(+124.6%) |
| Dec 2001 | $390.00 K(-50.5%) | $86.00 K(+13.2%) | $390.00 K(-11.6%) |
| Sept 2001 | - | $76.00 K(-24.8%) | $441.20 K(-25.3%) |
| June 2001 | - | $101.00 K(-20.5%) | $590.40 K(-16.2%) |
| Mar 2001 | - | $127.00 K(-7.4%) | $704.90 K(-10.5%) |
| Dec 2000 | $788.00 K(+16.2%) | $137.20 K(-39.1%) | $787.90 K(-9.9%) |
| Sept 2000 | - | $225.20 K(+4.5%) | $874.40 K(+7.0%) |
| June 2000 | - | $215.50 K(+2.6%) | $817.20 K(+1.9%) |
| Mar 2000 | - | $210.00 K(-6.1%) | $801.70 K(+10.8%) |
| Dec 1999 | $678.00 K(+69.1%) | $223.70 K(+33.2%) | $723.40 K(+20.4%) |
| Sept 1999 | - | $168.00 K(-16.0%) | $600.70 K(-5.1%) |
| June 1999 | - | $200.00 K(+51.9%) | $632.70 K(+18.8%) |
| Mar 1999 | - | $131.70 K(+30.4%) | $532.70 K(+6.3%) |
| Dec 1998 | $401.00 K(+33.7%) | $101.00 K(-49.5%) | $501.00 K(+25.3%) |
| Sept 1998 | - | $200.00 K(+100.0%) | $400.00 K(+33.3%) |
| June 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1997 | $300.00 K(+200.0%) | - | - |
| Sept 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| June 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $300.00 K(-75.0%) |
| Dec 1996 | $100.00 K(-96.7%) | - | - |
| Sept 1996 | - | $100.00 K(0.0%) | $1.20 M(-33.3%) |
| June 1996 | - | $100.00 K(0.0%) | $1.80 M(-25.0%) |
| Mar 1996 | - | $100.00 K(-88.9%) | $2.40 M(-20.0%) |
| Dec 1995 | $3.00 M | $900.00 K(+28.6%) | $3.00 M(+42.9%) |
| Sept 1995 | - | $700.00 K(0.0%) | $2.10 M(+50.0%) |
| June 1995 | - | $700.00 K(0.0%) | $1.40 M(+100.0%) |
| Mar 1995 | - | $700.00 K | $700.00 K |
FAQ
- What is AIM ImmunoTech annual revenue?
- What is the all time high annual revenue for AIM ImmunoTech?
- What is AIM ImmunoTech annual revenue year-on-year change?
- What is AIM ImmunoTech quarterly revenue?
- What is the all time high quarterly revenue for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly revenue year-on-year change?
- What is AIM ImmunoTech TTM revenue?
- What is the all time high TTM revenue for AIM ImmunoTech?
- What is AIM ImmunoTech TTM revenue year-on-year change?
What is AIM ImmunoTech annual revenue?
The current annual revenue of AIM is $202.00 K
What is the all time high annual revenue for AIM ImmunoTech?
AIM ImmunoTech all-time high annual revenue is $3.00 M
What is AIM ImmunoTech annual revenue year-on-year change?
Over the past year, AIM annual revenue has changed by +$61.00 K (+43.26%)
What is AIM ImmunoTech quarterly revenue?
The current quarterly revenue of AIM is $35.00 K
What is the all time high quarterly revenue for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly revenue is $900.00 K
What is AIM ImmunoTech quarterly revenue year-on-year change?
Over the past year, AIM quarterly revenue has changed by -$11.00 K (-23.91%)
What is AIM ImmunoTech TTM revenue?
The current TTM revenue of AIM is $190.00 K
What is the all time high TTM revenue for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM revenue is $3.00 M
What is AIM ImmunoTech TTM revenue year-on-year change?
Over the past year, AIM TTM revenue has changed by -$3000.00 (-1.55%)